Loading...

Summit Therapeutics Inc.

SMMTNASDAQ
Healthcare
Biotechnology
$27.57
$-0.44(-1.57%)

Summit Therapeutics Inc. SMMT Peers

See (SMMT) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
SMMT$27.57-1.57%20.5B-81.09-$0.34N/A
VRTX$472.27-0.98%121.3B-123.96-$3.81N/A
REGN$564.64-1.35%59.9B14.36$39.32+0.31%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$328.00+0.72%42.7B-155.32-$2.11N/A
ARGX$591.74+2.84%36.2B36.08$16.40N/A
BNTX$114.57-0.03%27.5B-30.88-$3.71N/A
RPRX$36.59+1.61%20.6B14.93$2.45+2.35%
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

SMMT vs VRTX Comparison

SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SMMT stands at 20.5B. In comparison, VRTX has a market cap of 121.3B. Regarding current trading prices, SMMT is priced at $27.57, while VRTX trades at $472.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SMMT currently has a P/E ratio of -81.09, whereas VRTX's P/E ratio is -123.96. In terms of profitability, SMMT's ROE is -0.70%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, SMMT is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.

Stock Price Comparison

Loading...

Frequently Asked Questions

;